BTLA and PD-1 signals attenuate TCR-mediated transcriptomic changes

BTLA and PD-1 signals attenuate TCR-mediated transcriptomic changes

Saved in:

Bibliographic Details
Main Authors:	Muhammad Zainul Arifin, Judith Leitner, Donagh Egan, Petra Waidhofer-Söllner, Walter Kolch, Vadim Zhernovkov, Peter Steinberger
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	iScience
Online Access:	http://www.sciencedirect.com/science/article/pii/S258900422500032X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The BTLA and PD‐1 signaling pathways independently regulate the proliferation and cytotoxicity of human peripheral blood γδ T cells
by: Hyun J. Hwang, et al.
Published: (2021-03-01)

Bioengineering Platelets Presenting PD‐L1, Galectin‐9 and BTLA to Ameliorate Type 1 Diabetes
by: Yumeng Ma, et al.
Published: (2025-04-01)

Direct cell interactions potentially regulate transcriptional programmes that control the responses of high grade serous ovarian cancer patients to therapy
by: Sodiq A. Hameed, et al.
Published: (2025-04-01)

BTLA agonist attenuates Th17-driven inflammation in a mouse model of steroid-resistant asthma
by: Christine Quach, et al.
Published: (2025-03-01)

A temporal model of tumor-immune dynamics during the metastatic progression of high-grade serous ovarian cancer
by: Donagh Egan, et al.
Published: (2025-06-01)

B and T lymphocyte attenuator (BTLA) and PD-1 pathway dual blockade promotes antitumor immune responses by reversing CD8+ T-cell exhaustion in non-small cell lung cancer
by: Yang Zhang, et al.
Published: (2025-05-01)

Integrated single-cell transcriptome and TCR profiles of hepatocellular carcinoma highlight the convergence on interferon signaling during immunotherapy
by: Xiaobo Li, et al.
Published: (2024-11-01)

Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients
by: L. Karabon, et al.
Published: (2020-01-01)

Early events in TCR signaling – the evolving role of ITAMs
by: Paul E. Love, et al.
Published: (2025-04-01)

Modifications to rhesus macaque TCR constant regions improve TCR cell surface expression.
by: Lori V Coren, et al.
Published: (2025-01-01)

Human TCR repertoire in cancer
by: Lin Chen, et al.
Published: (2024-09-01)

NetTCR-struc, a structure driven approach for prediction of TCR-pMHC interactions
by: Sebastian N. Deleuran, et al.
Published: (2025-07-01)

Deciphering the deterministic role of TCR signaling in T cell fate determination
by: Zhen Qin, et al.
Published: (2025-05-01)

Distinct Changes of BTLA and HVEM Expressions in Circulating CD4+ and CD8+ T Cells in Hepatocellular Carcinoma Patients
by: Jiayu Liu, et al.
Published: (2018-01-01)

Subset of DN Memory B Cells Expressing Low Levels of Inhibitory Receptor BTLA Is Enriched in SLE Patients
by: Lucie Aubergeon, et al.
Published: (2024-12-01)

Engineered PD-L1 co-expression in PD-1 knockout and MAGE-C2-targeting TCR-T cells augments the cytotoxic efficacy toward target cancer cells
by: Fangxin Zhao, et al.
Published: (2025-04-01)

Heterogeneity of CD8αα intraepithelial lymphocytes is transcriptionally conserved between TCRαβ and TCRγδ cell lineages
by: Kaito A. Hioki, et al.
Published: (2025-08-01)

High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells
by: Franziska Füchsl, et al.
Published: (2024-12-01)

Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies
by: Thomas Kuilman, et al.
Published: (2025-01-01)

Distinct characteristics of BTLA/HVEM axis expression on Tregs and its impact on the expansion and attributes of Tregs in patients with active pulmonary tuberculosis
by: Peijun Tang, et al.
Published: (2024-09-01)

Quantification of HTLV-1 clonality and TCR diversity.
by: Daniel J Laydon, et al.
Published: (2014-06-01)

Transferrin Disassociates TCR from CD3 Signaling Apparatus to Promote Metastasis
by: Ruomei Cheng, et al.
Published: (2025-01-01)

Separate signaling events control TCR downregulation and T cell activation in primary human T cells
by: Lieve E. H. van derDonk, et al.
Published: (2021-03-01)

Mutant p53-specific CD8TCR-therapy combined with a CD4TCR prevents relapse of cancer and outgrowth of micrometastases
by: Vasiliki Anastasopoulou, et al.
Published: (2025-12-01)

Numerical Analysis of a TCR Adaptive to Different Tree Diameters for Unstructured Forest Environment: A TCR of Variable Diameter with Different Tree Diameters
by: Zhe Wu, et al.
Published: (2023-01-01)

CAR’TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment
by: Karin Teppert, et al.
Published: (2024-06-01)

A comprehensive evaluation of diversity measures for TCR repertoire profiling
by: Justyna Mika, et al.
Published: (2025-05-01)

TCR-T cell therapy for solid tumors: challenges and emerging solutions
by: Wanjun He, et al.
Published: (2025-03-01)

Structural characterization of two γδ TCR/CD3 complexes
by: Mohammed Hoque, et al.
Published: (2025-01-01)

Circulating TCR γδ Cells in the Patients with Systemic Lupus Erythematosus
by: Ewa Robak, et al.
Published: (1999-01-01)

TCR-based cellular immunotherapy for hepatocellular carcinoma: advances, challenges, and prospects
by: Wanting Zeng, et al.
Published: (2025-07-01)

Exploiting TCR Repertoire Analysis to Select Therapeutic TCRs for Cancer Immunotherapy
by: Ursule M. Demaël, et al.
Published: (2025-08-01)

Regional distribution of HLA frequencies in the USA: implications for TCR-based therapies
by: Dirk Nagorsen, et al.
Published: (2025-05-01)

Dynamic allostery in the peptide/MHC complex enables TCR neoantigen selectivity
by: Jiaqi Ma, et al.
Published: (2025-01-01)

Comprehensive Analysis of TCR and BCR Repertoires: Insights into Methodologies, Challenges, and Applications
by: Kayoung Seo, et al.
Published: (2025-02-01)

TCR-Engineered, Customized, Antitumor T Cells for Cancer Immunotherapy: Advantages and Limitations
by: Arvind Chhabra
Published: (2011-01-01)

On Experimental Data of the TCR of TFRs and Their Relation to Theoretical Models of Conduction Mechanism
by: M. Wolf, et al.
Published: (1985-01-01)

Quantifying conformational changes in the TCR:pMHC-I binding interface
by: Benjamin McMaster, et al.
Published: (2024-12-01)

Tumor-Activated TCRγδ+ T Cells from Gastric Cancer Patients Induce the Antitumor Immune Response of TCRαβ+ T Cells via Their Antigen-Presenting Cell-Like Effects
by: Chaoming Mao, et al.
Published: (2014-01-01)

The fibrin-derived peptide FX06 protects human pulmonary endothelial cells against the COVID-19-triggered cytokine storm
by: Zhiran Wang, et al.
Published: (2025-06-01)